Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure (OSPREY-AHF)

NCT04334668 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT04334668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04334668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure (OSPREY-AHF)
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 20, 2020
Completion date
December 31, 2026
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

volume overload